Net profit of Fredun Pharmaceuticals rose 96.62% to Rs 10.48 crore in the quarter ended December 2025 as against Rs 5.33 crore during the previous quarter ended December 2024. Sales rose 57.04% to Rs 159.93 crore in the quarter ended December 2025 as against Rs 101.84 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 159.93 | 101.84 | 57 |
| OPM % | 16.46 | 12.98 | - |
| PBDT | 15.78 | 8.22 | 92 |
| PBT | 14.00 | 7.13 | 96 |
| NP | 10.48 | 5.33 | 97 |